Negotiating Terms Of Endosymbiosis

[THEO] Okay, picture this. You've got a cell — a nice, ordinary-looking cell — and living inside it, another organism. Not a virus hijacking the machinery. An actual second lifeform, with its own genome, running its own program, tucked inside the first one like a matryoshka doll.

[DR. MARA] And that arrangement is not exotic. Every eukaryotic cell you've ever seen is one — the mitochondrion was a free-living bacterium once. That's the deep version of this story. The cell within the cell is how complex life got built.

[THEO] Right, but what I love is that it's not just ancient history. This is happening right now, all over the place, at every stage of the process. Some of these partnerships are a billion years old and totally locked in. Some are, what, still negotiating the terms?

[DR. MARA] That's the framing I'd use. Endosymbiosis is a spectrum. On one end, an organelle that can't live alone anymore. On the other, a bacterium that's just moved in and hasn't committed. And the interesting biology — the tools we want to build — lives in the messy middle. How does one cell get inside another, feed there, talk to the host, and pass itself to the next generation?

[THEO] So before we trace the arc, let's define a few things for anyone who doesn't live in this world. When we say a symbiont is "vertically transmitted" —

[DR. MARA] It means it's passed from parent to offspring, usually through the egg. It never goes out into the environment as a free spore. Which sounds cozy until you're the scientist trying to study it, because you can't grow it in a dish and you can't purify it away from the host.

[THEO] And a couple of the tools that keep coming up — a T4SS is a type IV secretion system, basically a molecular syringe some bacteria use to inject proteins or DNA into a neighbor. And transposon sequencing, TnSeq, is where you knock out genes at random with a jumping-DNA element and see which knockouts fail. It's how you find the genes that matter without knowing them in advance.

[DR. MARA] Good. Hold onto both of those. Because the arc I want to walk starts with a question about that syringe.

[THEO] The 2017 Bartonella paper.

[DR. MARA] Yes. Bartonella is a genus of bacteria that infect animals — some cause disease in people. And there's this molecule, VbhT, a toxin. Toxin-antitoxin modules are ancient bacterial gadgets: a bacterium makes a poison and its own antidote, and the pair enforces things like plasmid inheritance. What the 2017 group showed is that this particular toxin gets shipped through a conjugative T4SS — the same apparatus bacteria use to swap DNA — straight into a neighboring bacterium.

[THEO] So a piece of internal bacterial housekeeping got repurposed into a weapon you fire at the cell next door.

[DR. MARA] An evolutionary intermediate. That's the word they use, and it's the through-line for the whole show. A module that policed the inside of one cell becoming a tool aimed at another cell. And the reason they could see it at all is a beautiful sensor. They call it CRAfT.

[THEO] This is the part I geeked out on. You put the enzyme Cre — a recombinase, it cuts and pastes DNA at specific sites called loxP — you fuse Cre onto the protein you think is getting delivered. The donor bacterium makes that fusion. The recipient carries a loxP switch that flips on antibiotic resistance only if Cre actually shows up inside it.

[DR. MARA] So translocation becomes survival. If the protein got delivered, the recipient lives on the plate. And the sensitivity there is the striking number — for a Cre-relaxase fusion, translocation hit essentially one hundred percent per donor cell, against maybe a tenth of a percent to one percent for transfer of the plasmid itself.

[THEO] Which tells you the protein moves way more readily than the DNA does. The syringe is really a protein syringe that sometimes drags DNA along.

[DR. MARA] That's the roots of it. Now jump to 2021, and the question shifts from mechanism to something more basic: how do you even study a symbiont you can't touch? The feminizing microsporidia paper.

[THEO] Feminizing — meaning the microbe turns genetically male hosts into functional females, because the symbiont only rides along in eggs. Sons are a dead end for it.

[DR. MARA] Exactly its incentive. These are microsporidia — fungal-adjacent intracellular parasites — living in Gammarus, a little freshwater crustacean. Strictly vertical, no purifiable spore. You cannot separate the symbiont DNA from the host DNA. So the authors didn't. They sequenced everything together and then computationally deconvolved it — pulled three separate microsporidian genomes plus a draft of the host out of one tangled pile of reads.

[THEO] That's the move, right? Stop fighting the biology, sequence the whole matryoshka doll at once and let the computer sort the layers.

[DR. MARA] And the payoff is evolutionary. They compared these feminizers to feminizing Wolbachia — a bacterium that does the same trick. Different kingdoms, and feminization evolved independently in both. Convergence. The candidate genes they nominate have DNA-binding and membrane-fusion functions, which is a plausible toolkit for reprogramming a host's sex.

[THEO] Two totally separate lineages arriving at the same manipulation. Okay, that same year — Midichloria.

[DR. MARA] My favorite name in microbiology. Midichloria mitochondrii is a bacterium that lives inside the mitochondria of ticks. Inside the organelle that itself descends from a bacterium.

[THEO] A cell, within a cell, within a cell. It's turtles.

[DR. MARA] The open question was how it moves. There was a Bdellovibrio-like model on the table — Bdellovibrio being a predatory bacterium that invades prey and bursts them. Does Midichloria lyse mitochondria to get around? This group did careful quantitative TEM — counting bacteria per mitochondrion in tick oocytes — and network simulation. And they reject the predatory model. It travels through the fused mitochondrial network, organelle to organelle, without destroying them.

[DR. MARA] The colonization followed a power-law distribution, and the traversal model explains that pattern where lysis doesn't. It's a tenant using the hallways, not a burglar breaking walls.

[THEO] So now we've got mechanism, we've got the unpurifiable-genome problem solved, we've got the physical life cycle. What ties the recent ones together?

[DR. MARA] Reading the conversation between host and symbiont at scale. The Akkermansia muciniphila work — a gut bacterium that eats mucin, the glycoprotein lining your gut. A transposon screen linked a pili-and-periplasmic complex, MUL, to actively importing mucin into internal compartments they call mucinosomes.

[THEO] The bacterium builds a little stomach inside itself for host material. And that same 2023 stretch has the review on barcoded TnSeq in gut commensals — RB-TnSeq — which is how you run these fitness screens in a living animal.

[DR. MARA] And then the spatial piece — SmT in the Arabidopsis phyllosphere. Multimodal arrays reading bacteria, fungi, and the plant's own transcriptome at once, at fifty-five microns. They found interkingdom interaction strength is quantitatively predicted by how much the partners share the same microbial hotspots.

[THEO] So the arc goes: how one cell fires a tool into another, to how you read a symbiont you can't isolate, to how it physically lives inside, to now — mapping the whole conversation in space.

[DR. MARA] From a single injected toxin to the full interactome. The cell within the cell stopped being a curiosity and became a system we can actually interrogate.

[THEO] And that's where we'll leave it. After the break — the mailbag, and somebody wrote in about tardigrades again.